Source link : https://www.newshealth.biz/health-news/fda-approves-third-ustekinumab-biosimilar/
The US Food and Drug Administration (FDA) has approved ustekinumab-ttwe (Pyzchiva) as a biosimilar to ustekinumab (Stelara) for the treatment of multiple inflammatory conditions. In addition, the agency “provisionally determined” that the medication would be interchangeable with the reference product but that designation would not take hold until the interchangeability exclusivity period for the first […]
Author : News Health
Publish date : 2024-07-01 19:59:40
Copyright for syndicated content belongs to the linked Source.
Categories